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Center of Biotechnology, Russian Academy of Sciences, Moscow, Russia; and 3Dedham, MassachusettsABSTRACT We investigated the functional impact of a-tropomyosin (Tm) substituted with one (D137L) or two (D137L/
G126R) stabilizing amino acid substitutions on the mechanical behavior of rabbit psoas skeletal myofibrils by replacing endog-
enous Tm and troponin (Tn) with recombinant Tm mutants and purified skeletal Tn. Force recordings from myofibrils (15C) at
saturating [Ca2þ] showed that Tm-stabilizing substitutions did not significantly affect the maximal isometric tension and the
rates of force activation (kACT) and redevelopment (kTR). However, a clear effect was observed on force relaxation: myofibrils
with D137L/G126R or D137L Tm showed prolonged durations of the slow phase of relaxation and decreased rates of the fast
phase. Both Tm-stabilizing substitutions strongly decreased the slack sarcomere length (SL) at submaximal activating [Ca2þ]
and increased the steepness of the SL-passive tension relation. These effects were reversed by addition of 10 mM 2,3-buta-
nedione 2-monoxime. Myofibrils also showed an apparent increase in Ca2þ sensitivity. Measurements of myofibrillar ATPase
activity in the absence of Ca2þ showed a significant increase in the presence of these Tms, indicating that single and double
stabilizing substitutions compromise the full inhibition of contraction in the relaxed state. These data can be understood with
the three-state (blocked-closed-open) theory of muscle regulation, according to which the mutations increase the contribution
of the active open state in the absence of Ca2þ (M). Force measurements on myofibrils substituted with C-terminal truncated
TnI showed similar compromised relaxation effects, indicating the importance of TnI-Tm interactions in maintaining the
blocked state. It appears that reducing the flexibility of native Tm coiled-coil structure decreases the optimum interactions
of the central part of Tm with the C-terminal region of TnI. This results in a shift away from the blocked state, allowing myosin
binding and activity in the absence of Ca2þ. This work provides a basis for understanding the effects of disease-producing
mutations in muscle proteins.INTRODUCTIONTropomyosin (Tm) is an a-helical, coiled-coil, actin-bind-
ing protein that together with troponin (Tn) regulates the
cooperative Ca2þ activation of striated muscle contraction.
Adjacent Tm molecules, each covering seven actin mono-
mers and interacting with one Tn (the so-called actin7TmTn
structural unit), bind head-to-tail and form a continuous
strand along the entire length of the actin filament, blocking
sites for myosin binding. When Ca2þ binds to Tn, the Tm
strand azimuthally moves and permits myosin access on
actin and cross-bridge formation (1–3). The different molec-
ular properties of Tm isoforms in vertebrate striated muscleSubmitted September 1, 2016, and accepted for publication December 8,
2016.
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 2016are involved in the dynamics of Ca2þ-induced Tm move-
ment on actin and the highly cooperative activation of
contraction (4,5). The stability of Tm is typical of two-
stranded, a-helical, coiled-coil proteins whose structure
consists of repeats of seven amino acid residues (a–g) that
form a hydrophobic core with residues 1 and 4 (a and d),
and is further stabilized by charged interchain interactions
between residues 5 and 7 (e and g) and polar interfaces
exposed to solvent (residues 2, 3, and 6, or b, c, and f
(6,7)). The modulation of Tm molecular stability by the
presence of single or clusters of noncanonical amino acids
(e.g., charged amino acids where hydrophobic ones are ex-
pected) seems to serve a relevant functional role by impart-
ing a variable degree of mobility to the protein (generally
referred to as flexibility). This could strongly impact Tm-
Tn interactions, Ca2þ regulation, and myosin cross-bridge
formation with actin. Interestingly, cardiomyopathy-linked
Tm Flexibility and Myofibril Relaxationmutations of Tm have been shown to affect molecular flex-
ibility, leading to the hypothesis that the modification of
flexibility could be a key factor in altered Ca2þ sensitivity
and phenotype pathological modifications (8). Among Tm
noncanonical amino acids, recent studies have examined
two highly conserved residues in the middle part of the
aaTm molecule: D137 (a charged residue in a d hydro-
phobic position) and G126 (a small, neutral residue in a g
charged position). Replacement of these residues with ca-
nonical ones, D137L and G126R (9,10), was shown in solu-
tion studies to significantly increase coiled-coil stability
and decrease molecular mobility or flexibility (9,11–13).
A significant decrease in the flexibility of reconstructed
thin filaments with the combined D137L/G126R substitu-
tion was also shown by means of the two-bead optical
trap technique (14).
Interestingly, Ca2þ regulation dynamics in the intact thin
filament are also affected, as shown by measurements of
thin-filament-induced activation of S1 ATPase activity in
the presence of D137L or G126R aaTm (9,10), and by
the maximal sliding velocity of regulated actin filaments
in in vitro motility assays (15,16). All of these studies re-
ported a clear functional change in the presence of one or
both stabilizing substitutions and a generalized increase in
apparent Ca2þ sensitivity. Regarding the functional impact
of Tm-stabilizing substitutions in organized sarcomeric
systems, little is known. The only available information
was obtained by the generation of a transgenic mouse model
expressing D137L aaTm (17), which led to a phenotype
alteration related to dilated cardiomyopathy and impair-
ment of both in situ cardiac function and cardiomyocyte
contractility.
Here, we investigated the functional role of Tm flexi-
bility in regulating the thin-filament-mediated activation
of muscle contraction by using single skeletal myofibrils,
a preparation that allows us to replace endogenous Tm
with recombinant forms, as well as to maintain a homoge-
neous protein composition in terms of posttranslational fea-
tures (18,19). In particular, the purpose of this work was to
determine the functional impact of recombinant aaTm car-
rying one (D137L) or two (D137L/G126R) substitutions on
the mechanical behavior of resting and maximally Ca2þ-
activated rabbit fast skeletal myofibrils, as well as on
their ATPase activity in the virtual absence of Ca2þ. The
results showed that both mutants decrease the ability of
the thin filament to completely switch off tension in
the absence of Ca2þ without affecting the kinetics and de-
gree of Ca2þ activation of force generation. The data were
very similar to what was observed by replacing cardiac
TnI (cTnI) with a C-terminal truncated form of cTnI in
skeletal myofibrils. Both sets of data can be explained by
the increased contribution of an active open state in the
absence of Ca2þ (M (20)) according to the three-state
muscle regulation theory (21). Furthermore, our results
support the hypotheses that the local and long-range flexi-bility of the Tm coiled-coil structure, as well as some inter-
actions of the Tm central part with TnI (2,22) and/or
myosin (16), may be crucial to maintain the full inhibition
of acto-myosin interactions of the resting state. These re-
sults confirm previous preliminary observations in skeletal
myofibrils replaced with D137LTm-Tn (23) or for a C-ter-
minal truncated form of cTnI (24).MATERIALS AND METHODS
Proteins
We used recombinant human aaTm (or Tpm1.1 according to (25)) with
an Ala-Ser N-terminal extension to imitate naturally occurring N-termi-
nal acetylation of native Tm (26). Human aaTm is almost identical to
rabbit aaTm (with only one conservative change, R220K), and N-termi-
nal modification of Tm has been shown to not interfere with the func-
tional properties of in vitro (26) and myofibril (27) systems. Also, the
three recombinants (control, D137L, and D137L/G126R) included the
mutation C190A to prevent air oxidation. As described previously (16),
all of these Tm species were overexpressed in BL21(DE3) according to
standard methods, extracted by heating, fractionated by reducing the
pH to 4.8, and purified by anion exchange chromatography using a
HiTrap QXL column. The C190A mutation mimics the reduced state
of cysteine in the Tm molecule, which is typical of living muscle (27),
and had no appreciable effect on the tryptic digestion of Tm (9) or on
its thermal unfolding and domain structure (12). Purified rabbit psoas
Tn was kindly provided by Prof. M.A. Geeves (University of Kent,
Kent, UK).Myofibril experiments: preparation and extraction
of endogenous Tm-Tn protein, and reconstitution
protocol
Single myofibrils or thin bundles of myofibrils were isolated from fast
psoas muscle of rabbits killed by pentobarbital (120 mg/kg) administra-
tion through the marginal ear vein in accordance with the official regula-
tions of the European Community Council on the Use of Laboratory
Animals (Directive 86/609/EEC) and using protocols approved by the
Ethics Committee for Animal Experiments of the University of Florence.
After dissection, muscles were cut in strips ~0.5 cm wide, tied at rest
length to rigid wood sticks, and stored at 20C for no more than
6 months in a 200 mM ionic strength rigor solution (100 mM KCl,
2 mM MgCl2, 1 mM EGTA, 50 mM Tris, pH 7.0) supplemented with
glycerol 50%. Single myofibrils or bundles of two to three myofibrils
were prepared by homogenization of glycerinated psoas muscle as previ-
ously described (28–30). All solutions were kept at ~0C and contained a
cocktail of protease inhibitors including 10 mM leupeptin, 5 mM pepstatin
A, 200 mM phenyl-methylsulphonylfluoride, 10 mM E64, 500 mM NaN3
and 500 mM dithiothreitol. In myofibrils, the endogenous regulatory pro-
teins Tm and Tn were extracted and replaced with recombinant human
aaTm forms and purified rabbit fast skeletal Tn as previously described
(18,27). The recombinant aaTm species replaced in myofibrils were then
control, D137L, and D137L/G126R. Briefly, myofibrils were washed by
centrifugation (five to seven times) in a mildly alkaline/low-ionic-
strength solution (2 mM Tris-HCl, pH 8.0) to remove native Tm and
Tn. Extracted myofibrils were then washed in rigor solution and
reconstituted with exogenous aaTm (5 mM) and Tn (2 mM) in a two-
step protocol (0C, 2 h incubation per step). Finally, the reconstituted
myofibrils were washed and stored in a 200 mM ionic strength rigor so-
lution at 4C and used within 3 days. In some experiments (see Fig. 7),
only the Tn complex was replaced with cardiac isoforms, using the pro-
cedure and proteins (cTnT, cTnC, and cTnI1-192) described in (31). AtBiophysical Journal 112, 376–387, January 24, 2017 377
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and pellet fractions for electrophoretic assays. SDS-PAGE gels (12%)
were prepared as previously described (31), stained with 0.1% Coomassie
blue, scanned, and analyzed using UN-SCAN-IT gel 6.0 software (Silk
Scientific, Orem, UT). Tm extraction and replacement were assessed in
each lane by the densitometry ratio of Tm to the actin band. Although
the Tm and TnT peaks overlapped in gel profiles, peaks of approximately
equal intensity were sufficiently separated for quantification. Myofibril
preparations that did not show the appropriate gel patterns were dis-
carded. Together with gel analyses of the bulk preparations, the mechan-
ical properties of the myofibrils after Tm-Tn replacement (maximal
calcium-activated force and its kinetics of development and relaxation)
were assessed as a key test for the preservation of actin/Tm/Tn
stoichiometry (18,19).Apparatus and experimental protocol
Mechanical measurements from Tm-Tn-replaced myofibrils in isometric
conditions were performed during activation-relaxation cycles achieved
by fast solution switching as previously described (28–30). For force
recording, a small volume of myofibril suspension was transferred to a
thermostatically controlled observation chamber mounted on an inverted
microscope (15C). Myofibrils in relaxing solution (pCa 9.0) were
mounted horizontally between two glass microtools: one connected to a
length-control motor and the other acting as a calibrated cantilevered
force probe (26 nm/nN; frequency response of 25 kHz). After
mounting, the initial length of selected preparations (single myofibrils
or bundles of a few myofibrils, 25–80 mm long, 1–4 mm wide) was set
just 5–10% above the slack length and the initial sarcomere length
(SL) was measured. Mounted myofibrils were then continuously perfused
by one of two streams of relaxing (pCa 9.0) or activating (pCa 4.5) solu-
tion flowing by gravity from a double-barreled glass pipette placed within
a 1 mm distance. The solution change, achieved by displacing the perfu-
sion pipette with a stepped-motor-controlled system, occurred with a time
constant of 2–4 ms and was complete in <10 ms. The maximal force
developed (P0) was measured by the deflection of the shadow of the force
probe projected on a split photodiode and normalized by the cross-
sectional area of the preparation. The rate of force development (kACT)
and the rate of force redevelopment according to the release-restretch
protocol (kTR) (32) were estimated from the time required to reach
50% of the maximal isometric force. The rate constant of the early
slow force decline (slow kREL) was estimated from the slope of the
regression line fitted to the tension trace normalized to tension just before
relaxation. The duration of the slow relaxation phase was estimated from
the start of the solution change. The rate constant for the final fast phase
of tension decline (fast kREL) was estimated from a monoexponential fit
(33,34). Resting tension development (RT) at pCa 9.0 was measured by
imposing up to 10–20% releases of initial length to myofibrils mounted
for force recording. By the same procedure, quasi-steady-state SL-resting
tension relations were determined several seconds after the imposition of
ramp elongations of different extents (10–30% of the initial myofibril
length), when most of the stress relaxation was over. In a few experi-
ments, the Ca2þ sensitivity of the force development of Tm-Tn-replaced
myofibrils was measured by a Ca2þ-jump protocol, i.e., by sequentially
activating myofibrils at submaximal (pCa 5.95) and maximal (pCa 4.50)
Ca2þ and measuring the ratio of developed force. The diameter, average
SL, and length of mounted myofibrils were measured by calibrated visual-
ization of video images.Solutions for mechanical experiments
All activating and relaxing solutions were calculated as described previ-
ously (30) at pH 7.0 and contained 10 or 1 mM of total EGTA (CaEGTA/
EGTA ratio set to obtain different pCa values in the range of 9.00–4.50),378 Biophysical Journal 112, 376–387, January 24, 20175 mM MgATP, 1 mM free Mg2þ, 10 mM 3-(N-morpholino) propanesul-
fonic acid, propionate, and sulfate to adjust the final solution to an ionic
strength of 200 mM and a monovalent cation concentration of 155 mM.
Creatine phosphate (10 mM) and creatine kinase (200 units/mL1)
were added to all solutions to minimize alterations in the concentration
of MgATP and its hydrolysis products. Contaminant [Pi] (~170 mM in
standard solutions) was reduced to <5 mM (Pi-free solutions) by a
Pi-scavenging enzyme system (purine-nucleoside-phosphorylase with
substrate 7-methyl-guanosine) (30,35). In a few experiments, 10 mM
2,3-butanedione 2-monoxime (BDM) was added to the relaxing solution.
All experimental solutions contained 10 mM leupeptin, cysteine protease
inhibitor E-64, and 0.5 mM dithiothreitol. Nucleoside phosphorylase
(bacterial), 7-methylguanosine, ATP, BDM, leupeptin, and E-64 were
purchased from Sigma-Aldrich (St. Louis, MO). Creatine phosphate
and creatine kinase were obtained from Roche Diagnostics (Basel,
Switzerland).ATP hydrolysis measurements from myofibril
suspensions
Steady-state ATP hydrolysis of Tm-Tn-replaced rabbit psoas myofibrils
in relaxing solution was measured using the Malachite Green phosphate
assay (BioAssay Systems, Hayward, CA). Briefly, myofibrils subjected
to the Tm-Tn extraction-replacement protocol were washed and resus-
pended with a modified relaxing solution that did not contain MgATP,
protease inhibitors, and creatine phosphate. The concentration of myosin
in the suspension was determined spectrophotometrically (36) from the
absorbance at 280 nm (BioSpectrometer, Eppendorf, Hamburg, Ger-
many) in 2% SDS, with E1%1cm ¼ 7 and assuming that myosin had a mo-
lecular mass of 5  105 D and represented 50% of the total protein
content (typically 0.2–0.3 mg/mL (36,37)). The mean head concentration
in reaction solution (250 mL) was set at ~0.5 mM. The reaction was
started in a constant-temperature bath at 30C by adding 50 mL of
5 mM MgATP dissolved in the same experimental solution (final con-
centration 1 mM). The reaction was arrested by acid quench at different
times by adding 250 mL of ice-chilled 0.67 M trichloroacetic acid.
The phosphate assay was performed by adding 20 mL of Malachite
Green reagent to 80 mL of the acid-quenched reaction mixtures and
measuring the absorbance at 630 nm after 30 min incubation at room
temperature. ATP hydrolysis was expressed as the ratio of [Pi ] to
[myosin head] (mM/mM).Data acquisition and analysis
Force and length analog signals were continuously monitored throughout
the experiments using commercial software and programs (LabVIEW, Na-
tional Instruments, Austin, TX) modified for our use. The same signals were
also recorded during experimental protocols and later used for data anal-
ysis. Data measurements were made directly with commercial software
(Origin) and an in-house-written LabVIEWanalysis program that converted
the analog signal to numeric values. The data are expressed and plotted as
the mean 5 SEM obtained from n myofibrils. Differences between the
three myofibril groups (control, D137L, and D137L/G126R aaTm) were
tested by means of unpaired Student’s t-tests. A value of p < 0.05 was
considered statistically significant.RESULTS
Reconstitution of rabbit psoas myofibrils with
mutant Tms
The substitution of three different mutant aaTms (control,
D137L, and D137L/G126R) for native Tm in myofibrils
Tm Flexibility and Myofibril Relaxationwas performed by extraction and reconstitution of Tm-
Tn in a two-step process, as outlined in Materials and
Methods. Samples of all myofibril preparations used for
mechanical measurements were retained for SDS-PAGE
analysis, as well as native (unextracted) and Tm-Tn-
extracted myofibrils. Fig. 1 A shows a representative
electrophoretic gel of samples from D137L Tm-Tn-
extracted and -reconstituted myofibrils. The amount of
protein loaded (4–10 mg) in the different lanes differed
slightly due to protein loss during the preparation. The de-
gree of Tm extraction and replacement in each lane was
quantified from the intensity profiles of scanned gels. The
mean data reported in Fig. 1 B show that after extraction,
the Tm/actin ratio of myofibrils dropped from 0.53 5
0.01 (native) to 0.11 5 0.01 (extracted) and then almost
fully recovered, independently of the recombinant aaTm
used. These results indicate that 80% 5 1% of Tm wasFIGURE 1 Tm-Tn reconstitution in rabbit skeletal myofibrils. (A)
Representative Coomassie blue-stained 12% SDS-PAGE gel image of
the extraction and reconstitution of regulatory proteins in rabbit psoas
skeletal myofibrils using D137L aaTm. Native, extracted, and D137L
aaTm-Tn-reconstituted myofibrils are shown on the right. A skeletal
Tn complex and D137L aaTm are shown on the left. (B) Efficiency of
extraction-reconstitution with different aaTm molecules in rabbit skel-
etal myofibrils, averaged from a densitometry analysis of SDS-PAGE
gels. Myofibrils were extracted and replaced with Tn and control,
D137L, or D173L/G126R aaTm. Tm band intensities are expressed rela-
tive to the corresponding actin band. All values are given as mean 5
SEM (the number of averaged gels is given above the bars). From the
left, Tm/actin density ratios: native, 0.53 5 0.01; extracted, 0.11 5
0.01; control, 0.50 5 0.02; D173L, 0.50 5 0.03; D173L/G126R,
0.52 5 0.02.removed and Tm replacement in reconstituted myofibrils
attained 95% 5 2%, 96% 5 2%, and 97% 5 2% with
control, D137L, and D137L/G126R, respectively (mean
5 SEM; n ¼ 6–14). As expected, extraction/replacement
of fast skeletal Tn was 100% (19).D137L and D137L/G126R Tms do not affect
myofibril activation kinetics and maximal
isometric tension, but impair relaxation
Representative mechanical recordings of active force
development, force redevelopment, and relaxation of myo-
fibrils reconstituted with control, D137L, and D137L/
G126R are shown in Figs. 2 A and 3 A. In each activation
(pCa 4.5)-relaxation (pCa 9.0) cycle was performed
by fast solution switching, the following data were
obtained: 1) maximal steady-state tension (P0, force devel-
oped at pCa 4.5 normalized over myofibril cross-sectional
area); 2) the rate of force development upon maximal
Ca2þ activation (kACT); and 3) the rate of tension rede-
velopment upon a rapid 20% release-restretch imposed
at maximal activation (kTR). Average values are shown
in Fig. 2 B.
The average rates of the slow linear and fast exponential
phases of full force relaxation (slow kREL and fast kREL,
respectively), as well as the duration of the slow phase
of force relaxation (33), are reported in Fig. 3, B–D. The
activation-relaxation traces show that Ca2þ regulation of
contraction is well preserved in myofibrils reconstituted
with all of the aaTms used here, with no significant differ-
ence in maximal tension, rate of activation (kACT), or rate
of tension redevelopment (kTR). This confirms the effective
reconstitution of the exogenous regulatory proteins into
the sarcomere after extraction, as already suggested by
electrophoretic analysis, and shows that Tms with reduced
flexibility do not impair maximal force generation or
the kinetics of its development after Ca2þ activation.
However, the force relaxation transients of the mutant
myofibrils compared with control myofibrils showed a
marked difference, with clearly increased effects associ-
ated with the presence of two Tm-stabilizing substitutions
(D137L/G126R) compared with one (D137L). As shown
in Fig. 3 A, myofibrils reconstituted with D137L/G126R
Tm exhibited a markedly prolonged duration of the slow
phase of relaxation (Fig. 3 B; p < 0.0005) and a signif-
icant decrease in the rate of the fast phase of relaxation
compared with myofibrils with control Tm (Fig. 3 D;
p < 0.0005). Smaller but similar effects were observed
with D137L Tm. The rate of the slow isometric force
decay was unchanged by the mutant Tms (Fig. 3 C), as
expected from previous observations regarding the lack
of effect of Tm isoforms (19) or Tm posttranslation
modifications (38) on this parameter. Interestingly, the
changes in relaxation associated with the presence of these
substitutions in the central part of aaTm are similar to theBiophysical Journal 112, 376–387, January 24, 2017 379
FIGURE 2 Maximal isometric active tension
generation in rabbit psoas myofibrils containing
recombinant control, D137L, or D137L/G126R
aaTm at 15C. (A) Representative recordings (top
traces) of force development of control aaTm
(left), D137L aaTm (middle), and D137L/G126R
aaTm (right) reconstituted skeletal myofibrilsmaxi-
mally activated (pCa 4.5) and fully relaxed (pCa 9.0)
by the fast solution switching technique. Bottom
traces show where the rapid release (20% l0) and re-
stretch ofmyofibril lengthwas performed tomeasure
the exponential redevelopment of force (kTR) under
steady maximal tension conditions. The rate of ten-
sion generation after fast Ca2þ activation (kACT)
wasmeasured from thekinetics of force development
upon solution switching from a relaxing to an acti-
vating solution. Bars above the traces correspond
to the timing of the solution change, and numbers
correspond to pCa values of activating and relax-
ing solutions. Tension calibration (vertical bar):
100 mN mm2; time calibration (horizontal bar):
1 s. Control aaTm: SL 2.50 mm, P0 409 mN mm
2, kACT 6.7 s
1, kTR 6.2 s
1 D137L aaTm: SL 2.31 mm, P0 436 mN mm
2, kACT 6.9 s
1, kTR 6.0 s
1;
D137L/G126R aaTm: SL 2.09 mm, P0 mNmm
2, kACT 6.8 s
1, kTR 6.5 s
1. (B) Average values of the kinetics and maximal active and resting tensions of rabbit
psoasmyofibrils reconstituted with recombinantaaTm species at 15C. All values aremean5 SEM (pCa 4.5) and each group of datawas obtained from different
skeletal myofibril batches (numbers in parentheses are the number of myofibrils). *p< 0.0001, #p< 0.01 (Student’s t-test) versus the same parameter measured
in control aaTm-reconstituted myofibrils.
Scellini et al.relaxation dynamics observed for incomplete/impaired
switching-off of the regulatory apparatus of native Tm,
as in the case of relaxation from maximal to submaximal
activating [Ca2þ] (33), or in the presence of mutated reg-
ulatory proteins unable to completely inhibit acto-myosin
interactions in the absence of Ca2þ (e.g., 20,31). Residual
thin-filament activation after Ca2þ removal that allows the
recruitment of new force-generating cross-bridges may becontrol aaTm-reconstituted myofibrils. #p < 0.05 (Student’s t-test) versus t
p < 0.002 (Student’s t-test) versus the same parameter measured in D137L aaT
380 Biophysical Journal 112, 376–387, January 24, 2017responsible for the slower relaxation kinetics observed
here.D137L and D137L/G126R Tms impair the resting
properties of myofibrils
As shown in Fig. 2 B, compared with control myofibrils,
both D137L and D137L/G126R Tm myofibrils mountedFIGURE 3 Relaxation kinetics of rabbit psoas
myofibrils containing recombinant control, D137L,
or D137L/G126R aaTm at 15C. (A) Time
course of full-force relaxation frommaximal activa-
tion of representative control and D137L/G126R
aaTm-reconstituted myofibrils, obtained by fast
solution switching from pCa 4.5 back to a pCa 9.0
relaxing solution. The same traces as in Fig 2 A
were normalized and presented on an expanded
timescale to show the kinetics of force relax-
ation. Dark gray trace: control aaTm myofibril
(duration of slow phase: 129 ms; slow kREL ¼
1.7 s1; fast kREL ¼ 13.4 s1). Light gray
trace: D137L/G126R aaTm myofibril (duration of
slow phase: 91 ms; slow kREL ¼ 1.6 s1; fast
kREL ¼ 38.5 s1). (B) Mean values of the duration
of slow-phase relaxation. (C) Mean values of the
rate of the slow phase of relaxation (slow kREL).
(D) Mean values of the rate of the fast phase of
relaxation (fast kREL). Histogram columns: control
(white), D137L (light gray), and D137L/G126R
aaTm (dark gray) myofibrils. Bars above the
columns are SEM, and the number of myofibrils
is shown above the bars. *p < 0.0005 (Student’s
t-test) versus the same parameter measured in
he same parameter measured in control aaTm-reconstituted myofibrils.
m-reconstituted myofibrils.
Tm Flexibility and Myofibril Relaxationon the force-recording apparatus in relaxing solution (see
Materials and Methods) had ~10% shorter initial SLs (p <
0.0001) as well as increased resting tension (p < 0.01).
To understand whether this change was related to the incom-
plete switch-off state of thin filaments suggested by the
alterations of relaxation dynamics, the mean slack SL of
control, D137L, and D137L/G126R Tm reconstituted myo-
fibrils was also measured for free myofibrils in relaxing
solution, i.e., lying on the bottom of the experimental cham-
ber. In this condition, as shown in Fig. 4 C, the SLs of
control aaTm myofibrils (2.08 5 0.02 mm) were signifi-
cantly longer than those of D137L aaTm and D137L/
G126R aaTm myofibrils, and the difference increased
significantly from the single to the double substitution
(1.95 5 0.02 mm and 1.83 5 0.03 mm, respectively; p <
0.0001). This difference was almost completely abolished
by the addition of 10 mM BDM, an inhibitor of strong
cross-bridge formation (21,35,39). As shown in Fig. 4 D,
BDM did not significantly change the SL of control
aaTm myofibrils (2.13 5 0.02 mm), but increased the
SLs of both D137L and D137L/G126R aaTm myofibrils
by ~10–15% (2.105 0.02 mm and 2.075 0.03 mm, respec-
tively), bringing the values close to those measured in
control aaTm myofibrils. This is a strong indication of the
presence of a significant amount of Ca2þ-independent,actively cycling cross-bridges in myofibrils replaced with
these aaTm mutants, and this is greater for the double
mutant.
To further investigate the passive properties of D137L and
D137L/G126R aaTm exchanged myofibrils, quasi-steady-
state SL-resting-tension relations were determined under
normal relaxing conditions or in the presence of 10 mM
BDM (Fig. 4, A and B). Elongations of increasing extents
(up to 30%) were applied to the different myofibril groups,
and the SL and resting tension were measured several sec-
onds after each length change (when most of the stress
relaxation was over) by imposing large releases that
dropped the tension to zero (Fig. 4 A, inset, shows a repre-
sentative tension trace for a control and a D137L aaTm
myofibril). The average SL-resting-tension relations in re-
laxing solution are shown in Fig. 4 A for control, D137L,
and D137L/G126R myofibrils. Clearly, D137L/G126R
myofibrils exhibited a higher resting stiffness compared
with control myofibrils. In D137L myofibrils, the effect
was much smaller and mostly due to the difference in the
initial SL. As shown in Fig. 4 B, the addition of 10 mM
BDM almost completely abolished these differences, further
supporting the hypothesis that these mutants prevent full
inhibition of the acto-myosin interaction at low resting
[Ca2þ].FIGURE 4 SL and Ca2þ-independent tension of
control, D137L, and D137L/G126R aaTm-recon-
stituted myofibrils. (A) Average SL-resting-tension
relationships of myofibrils extracted and recon-
stituted with control (white square), D137L (light
gray square), or D137L/G126R (dark gray square)
aaTm. Data points at different SLs are means 5
SEM (vertical and horizontal bars) of resting-
tension values measured in five to nine individual
myofibrils. Inset, lower trace: representative trace
of 30% l0 step release applied to a myofibril
at pCa 9.0; upper traces: Ca2þ-independent force
response for control aaTm and D137L aaTm
mounted myofibrils. Tension calibration (vertical
bar): 40 mN mm2; time calibration (horizontal
bar): 50 ms. (B) Effect of 10 mM BDM on average
SL-resting-tension relationships for the different
groups of Tm-Tn-replaced myofibrils. (C) Mean
slack SL of free control, D137L, and D137L/
G126R Tm-reconstituted myofibrils measured in
relaxing solution. The SLs in the presence ofmutant
aaTm are significantly shorter compared with con-
trol aaTm myofibrils (*p < 0.0001). SLs are also
considerably shorter in D137L/G126R aaTmmyo-
fibrils than inD137LaaTmmyofibrils (# p< 0.01).
(D) Effect of 10 mM BDM on the mean slack SLs
of control, D137L, and D137L/G126R aaTm-
reconstituted myofibrils. All values (mm) are
given as mean 5 SEM: control aaTm 2.08 5
0.02, control þ BDM 2.135 0.02; D137L aaTm
1.95 5 0.02, D137L þ BDM 2.10 5 0.02;
D137L/G126R aaTm 1.83 5 0.03, D137L/
G126R þ BDM 2.07 5 0.03. The number of
myofibrils is given above the bars.
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FIGURE 5 Myofibrillar ATPase at low [Ca2þ] is much greater for recon-
stituted myofibrils containing D137L (light gray square) and D137L/
G126R (dark gray square) compared with control aaTm (white square)
(30C). (A) ATPase activity of reconstituted myofibrils measured in relax-
ing solution (pCa 9.0). Each point is the mean 5 SEM of four measure-
ments (five for control aaTm). The steady-state ATPase rate was
obtained from regression lines (dotted lines) fitted on all individual data
points. (B) Average slope of regression lines (steady-state rate; s1) of
replaced myofibrils: control aaTm 0.40 5 0.07; D137L aaTm 0.71 5
0.13; D137L/G126R aaTm 0.665 0.06. The steady-state rate was signif-
icantly increased in D137L/G126R aaTm compared with control aaTm
myofibrils (*p < 0.05, Student’s t-test).
Scellini et al.D137L and D137L/G126R Tms increase the resting
ATPase activity of myofibrils
We further investigated the greater degree of Ca2þ-inde-
pendent active cross-bridge formation in D137L and
D137L/G126R aaTm compared with control myofibrils by
measuring steady-state ATPase activity in relaxing solution
(seeMaterials andMethods). Fig. 5A showsmean data points
from four to five experiments measuring the time course of
inorganic phosphate (Pi) formation after addition of a large
excess of Mg-ATP to myofibril batches collected at different
times after trichloroacetic acid quench (60–360 s). The initial
rapid transient formation of Pi was not resolved in our condi-
tions. As shown in Fig. 5 A, myofibrils reconstituted with
aaTmwith single or double stabilizing substitutions showed382 Biophysical Journal 112, 376–387, January 24, 2017a clear increase in resting steady-state ATP hydrolysis when
compared with control aaTm reconstituted myofibrils. The
increasewas significant for D137L/G126R aaTmmyofibrils
(p< 0.05). For D137L aaTm-enriched myofibrils, the effect
was somewhat smaller (p ¼ 0.06). The mean slope values
of the regression lines used to estimate the steady-state
ATP hydrolysis rate were 0.40 5 0.07 s1, 0.71 5
0.13 s1, and 0.66 5 0.06 s1 for control, D137L, and
D137L/G126R aaTm, respectively (Fig. 5 B). These results
further strengthen the hypothesis regarding an inhibition of
the switch-off mechanism associated with the presence of
D137L or D137L/G126R aaTm in the thin filament.D137L and D137L/G126R Tms increase the
apparent Ca2D sensitivity of tension
We also investigated the Ca2þ dependence of tension gener-
ation in D137L aaTm-replaced myofibrils by comparing
force generation at submaximal and maximal [Ca2þ] activa-
tions. Control and D137L aaTm myofibrils were activated
by rapid solution switching, first submaximally (pCa 5.95)
and then maximally (pCa 4.50). Representative tracings of
these Ca2þ-jump experiments are shown in Fig. 6 A together
with the mean tension ratio values (Fig. 6 B). The ratio of
submaximal to maximal tension was significantly higher
(~50%) in D137L aaTm compared with control aaTm-
replaced myofibrils (p < 0.02). These results apparently
indicate that D137L aaTm imparts a significant increase
of myofilament Ca2þ sensitivity. However, this could also
be explained by the observation of the involvement of active
cross-bridges in the absence of Ca2þ, whose contribution
decreases with increasing Ca2þ concentration. This would
produce a force/pCa2þ curve shifted to lower [Ca2þ] (20)
without an actual change in Ca2þ sensitivity.C-terminal truncated cTnI shows inhibition of
relaxation similar to that observed for D137L and
D137L/G126R Tms in myofibrils
Functional modifications similar to those reported here for
D137L and D137L/G126R substitutions in aaTm were
also observed in rabbit psoas myofibrils exchanged with a
truncated TnI subunit (cTnI1-192) that was unable to fully
inhibit acto-myosin interactions in the absence of Ca2þ
(24,31). As shown in Fig. 7 A, when a C-terminal truncated
form of TnI (cTnI1-192) was replaced in myofibrils for full-
length TnI, full-force relaxation from maximal activation
was slowed down compared with controls, i.e., compared
with unexchanged myofibrils (native (Nat)) or with myofi-
brils replaced by full-length cTnI (cTnIFL). This is similar
to what was observed for D137L and D137L/G126R
aaTm mutations, i.e., a significant increase in the duration
of the slow phase of relaxation (Fig. 7 B) and a decrease
in both rates of relaxation (Fig. 7, C and D), which was
significant for the fast phase (*p < 0.01). Moreover, the
FIGURE 6 D137L aaTm-reconstituted myofibrils show a greater active
tension than control at submaximal Ca2þ activation. (A) Myofibrils replaced
with control aaTm (upper trace) and D137L aaTm (lower trace) were acti-
vated at pCa 5.95 and then subjected to [Ca2þ] jumps to pCa 4.50 at 15C.
At each level of Ca2þ activation, a release-restretch was applied to the prep-
aration under steady-state conditions of tension generation. Bars above the
traces correspond to the timing of the solution change, and numbers corre-
spond to the pCa values of relaxing, submaximal, and maximal activating
solutions. Tension calibration (vertical bar): 100 mN mm2; time calibra-
tion (horizontal bar): 1 s. Control aaTmmyofibril: SL 2.31 mm, resting ten-
sion 20 mN mm–2, Po 5.95/Po 4.50 ¼ 0.17; D137L aaTm myofibril: SL 2.18
mm, resting tension 90 mNmm–2, Po 5.95/Po 4.50¼ 0.36. (B) Mean values for
the ratio of submaximal pCa 5.95 to maximal pCa 4.5 activated tension
obtained from [Ca2þ] jump experiments in control and D137L aaTm-
replaced myofibrils. Values are given as means 5 SEM; numbers in
parentheses are the number of myofibrils; *p < 0.02, Student’s t-test.
Tm Flexibility and Myofibril RelaxationBDM-sensitive increase in resting tension (Fig. 7 E)
observed in the presence of cTnI1-192 is almost superimpos-
able with that observed for D137L and D137L/G126R
aaTm mutations. Because structural (2) and photo-cross-
linking (22) studies have shown that the C-terminal region
of TnI interacts with actin and the central region of aaTm
(at residue 146) in a Ca2þ-dependent manner, the removal
of that region would critically reduce inhibition of acto-
myosin interactions in the absence of Ca2þ (40). A loss of
interaction of C-terminal TnI with the region of aaTm
around 146 due to the 137 and 126 mutations could explain
the inhibition of relaxation observed here (see Discussion).DISCUSSION
In this study, we used tension measurements on single
myofibrils (28–30) to study the functional impact ofsubstituting stabilizing canonical amino acid residues for
highly conserved native residues in aaTm at positions
137 and both 137 and 126 (D137L and D137L/G126R,
respectively). All of the Tm forms used in this study had
the C190A substitution, eliminating the possibility of sulf-
hydryl oxidation and thereby mimicking the physiological
reduced state of Tm in sarcomeres of rabbit psoas muscle
(41). Only minor structural changes occur when Cys190
is replaced by an Ala (11,12), and myofibrils reconstituted
with C190A Tm-Tn (controls) show no functional alter-
ation compared with myofibrils reconstituted with native
Tm (data not shown). C190A Tm-Tn-replaced myofibrils
were then used as a control for a comparative study with
D137L or D137L/G126R Tm-Tn to eliminate the possibil-
ity of a change in the properties of myofibrils subjected
to the Tm-Tn extraction-reconstitution procedure (18,27).
Moreover, Tm in these native myofibrils consists of a 3:1
to 4:1 mixture of a and b isoforms with a 50:50 mixture
of aaTm and abTm (42). By replacing abTm with
aaTm, we minimized the possible influence of abTm on
Ca2þ regulation (19).Relaxation impairment and the three-state theory
In contrast to the lack of appreciable effect on the ki-
netics of activation and active force at saturating Ca2þ,
the presence of Tm mutants importantly affected myofibril
relaxation with the following functional consequences: a
prolongation of relaxation (Fig. 3), a decrease in initial
SL eliminated by BDM (Fig. 4), a twofold increase in
resting tension (Fig. 2 B), a 50% increase in resting
ATPase (Fig. 5), and an apparent increase in Ca2þ sensi-
tivity (Fig. 6). Relaxation from the fully turned on myofi-
bril system by Ca2þ removal consisted of two kinetic
processes: a slow linear tension decrease and a fast expo-
nential tension decrease (Fig. 3 A). The former reflects
cross-bridge detachment from maximal Ca2þ under iso-
metric conditions of the sarcomeres. The latter is initiated
by sarcomere give and dominated by sarcomere dynamics
(43,44), and its rate mainly depends on the isoform of
the myosin heavy-chain motor (34). The persistence of
cycling cross-bridges after Ca2þ removal can keep the sys-
tem active, resulting in a prolongation of the duration of
the slow phase and a slowing down of the fast relaxation
phase (see Fig. 5 C in Ref. 33). These results point toward
the involvement of force-generating cross-bridges in inhib-
iting relaxation, and can be explained by shifting equilibria
among the three states of muscle regulation (blocked-
closed-open), which relates the properties of myosin
binding to actin7TmTn (45) with the Tm structural position
on actin (3,4). In the three-state model, Tm bound to
actin equilibrates among the blocked-closed-open states,
with Ca2þ allosterically affecting the first equilibrium
and myosin the second equilibrium. The open state is the
active state and is often termed the M-induced or M state.Biophysical Journal 112, 376–387, January 24, 2017 383
FIGURE 7 Relaxation kinetics and SL-resting-
tension relationship of rabbit psoas myofibrils
after exchange of endogenous TnI with a C-termi-
nal truncated TnI form (cTnI1-192) at 15
C. (A)
Time course of full-force relaxation from maximal
activation of native (unexchanged) myofibrils
(Nat, black line) and myofibrils in which whole
native Tn had been replaced (by exchange)
by cTn, including either the full-length (cTnIFL,
gray line) or truncated (1–192 (cTnI1-192), dark
gray line) cTnI subunit, normalized and presented
on an expanded timescale to show the kinetics of
force relaxation. (B) Mean values of the duration
of slow-phase relaxation. (C) Mean values of the
rate of the slow phase of relaxation (slow kREL).
(D) Mean values of the rate of the fast phase of
relaxation (fast kREL). *p < 0.01 versus the same
parameter measured in cTnIFL and native unex-
changed myofibrils. The number of myofibrils is
given above the bars. (E) Average SL-resting-
tension relationships of myofibrils replaced with
either cTnIFL (gray solid circle) or cTnI1-192
(dark gray square). BDM (10 mM) completely
abolishes the difference in passive tension (open
square, cTnI1-192; open circle, cTnIFL). Vertical
and horizontal bars are SEM. Resting tension and
mean SL were measured under quasi-steady-state
conditions.
Scellini et al.The observation that the system is still active in the
absence of Ca2þ shows that there is a contribution from
the open- or myosin-induced state that could be caused
by a loss of blocked state, leading to increased myosin
binding in the closed state or a direct effect of strong
myosin binding to increase the open state. We recently
proposed a myosin-induced open state to explain relaxation
effects due to mutations that cause hypertrophic cardiomy-
opathy (HCM), termed M (20). The M-open state is free
of Ca2þ, in contrast to the Mþ-open state, which has Ca2þ
bound to TnC. In the open state, whether Ca2þ is present
(Mþ) or not (M), Tm does not block myosin binding
and therefore allows active cycling. The increase of the
duration of the slow phase of relaxation, the slowing of
the fast phase (Fig. 3), and the increase of the residual
resting tension for the mutants (Fig. 2 B) indicate a greater
contribution of the M state in the case of the mutants. The384 Biophysical Journal 112, 376–387, January 24, 2017apparent increase in the Ca2þ sensitivity of tension (Fig. 6),
however, is due to the contribution of the residual tension
produced by the M state, which decreases as the [Ca2þ]
increases (20).D137L and D137L/G126R Tm interactions in the
thin filament
In view of the coupled equilibria in the three-state theory, a
changed interaction between Tm and any of the other com-
ponents (actin, Tn, and myosin) could explain the inability
of muscle to completely relax in the absence of Ca2þ. The
inhibition of relaxation observed for these mutants may be
explained by our observation that cTnI containing a C-ter-
minal truncation, cTnI1-192, produced relaxation properties
very similar to those found for the Tm mutants, e.g., a slow-
ing down and incomplete inhibition of tension (Fig. 7). This
Tm Flexibility and Myofibril Relaxationeffect is not due to the presence in skeletal thin filaments of
the cardiac isoform of TnI (presenting an N-terminal exten-
sion), as proved by the lack of effects in cTnI-replaced
myofibrils compared with native control samples. Structural
studies with cTnI1-192 have indicated that the C-terminal
region does affect the position or state of Tm on actin
(39). At the same time, functional studies have indicated
that when cTnI1-192 is present in the Tn complex, cross-
bridge formation in the absence of Ca2þ is not fully
inhibited, with impaired inhibition of the resting ATPase
of reconstituted cardiac systems (46), impaired relaxation,
and an apparent increase in the Ca2þ sensitivity of replaced
cardiac myofibrils (31). Similar effects were produced with
the TnI HCM mutant R146W-cTnI (47), which appeared to
shift the equilibrium away from the blocked state (20). Inter-
estingly, cross-linking (22) and structural (48) data show an
interaction of TnI with Tm in the absence of Ca2þ. Thus,
loss of this interaction with the Tm mutants appears to be
the cause of the relaxation impairment. Our previous studies
showed that these mutations increase the stability or dy-
namic rigidity of Tm in solution (9,10,12). It is possible
that this loss of conformational mobility contributes to the
loss of a specific interaction between Tm and a region in
the C-terminus of TnI.
Previous results have shown that these stabilizing mutants
do not alter the Tm-actin binding capability (9,16), likely
preserving the preshaped Tm configuration (Gestalt-binding
(49)) despite the presence of some long-range overall mo-
lecular straightening and local stiffening (11). Myosin has
been shown to dissociate TnI from actin7TmTnI (22), indi-
cating a direct shift in the actin-Tm state from blocked to
open. Also, evidence has been obtained for an interaction
between myosin and Tm in the M state from cross-
linking studies (50) and structural studies (51), which may
be facilitated by these mutants. Evidence for changed
myosin-Tm interactions and TnI-Tm interactions could be
obtained from binding studies of myosin subfragment 1
and TnI with mutant Tm in thin filaments.
In view of the increased duration of the slow relaxation
phase in the myofibril, another connection to the increased
stability/rigidity properties of the mutants is possible. Tm
in the thin filament interacts with seven actin subunits and
with itself end-to-end, forming a continuous strand along
actin. The cooperative unit size, n, in the reconstituted
thin filament (actin7TmTn), however, was shown to be
n ¼ 10–12, due to strong end-to-end interactions facili-
tated by Tn (20). The greater duration of the slow phase
of relaxation for the mutants observed here suggests a
greater communication between neighboring structural
units, with a bound head at one actin site keeping many
neighboring sites open via a more rigid Tm. For these mu-
tants, it would be interesting to verify this proposed mecha-
nism for the change in n by conducting in vitro kinetic
studies on reconstituted thin filaments with labeled Tm, as
previously performed on native systems (20).HCM mutants E180G and D175N and impairment
of relaxation
The contribution of the M-active state has been proposed
to explain similar impaired relaxation properties of thin-
filament proteins containing mutations that cause HCM
(4,20). In particular, aaTm E180G and D175N have shown
a similar incomplete relaxation and apparent increase in
Ca2þ sensitivity (52–54). In these cases, the effects were
also explained by a shift in the equilibrium from the blocked
state to the closed state, resulting in increased myosin
binding to produce the M-open state. In contrast to the
mutant Tms examined here, in which increased rigidity
was observed, the inhibition of relaxation observed for the
HCM mutants was associated with decreased rigidity or
increased flexibility, possibly affecting the Tm-actin interac-
tion. Other HCM mutations in muscle proteins can produce
inhibition of relaxation depending upon the effect on the
coupled equilibria (blocked-closed-open) in this multicom-
ponent allosteric system (20).Discrepancies with previous studies
The results of this investigation do not fully agree with those
reported in a previous study involving a transgenic (TG)
mouse model for D137L aaTm (17). In that study, an
in vitro characterization of D137L aaTm confirmed previ-
ous data (9) as well as a long-range molecular rearrange-
ment seen in structural studies (11,12). However, the TG
mouse study (17) reported that D137L aaTm had no effect
on acto-myosin ATPase of reconstituted myofilaments,
whereas a clear increase had been previously reported (9)
and is confirmed by our data. Moreover, the D137L TG
mouse showed a clear decrease of in situ cardiac function
and cardiomyocyte contractility in terms of force and
Ca2þ sensitivity, which does not agree with our observations
in Tm-Tn-replaced rabbit psoas myofibrils. This discrep-
ancy could be explained by the different experimental con-
ditions used (cardiac versus skeletal) as well as the uncertain
assessment of protein content (isoforms and posttransla-
tional modified forms) in the sarcomeres of the TG
mice. Studies of the functional consequences of replacing
D137L or D137L/G126R aaTm in cardiac myofibrils could
help to clarify this point.CONCLUSIONS
We used the novel, to our knowledge, approach of
monitoring the mechanical properties of single myofibrils
containing mutant Tms with one or two stabilizing amino
acids substituted for native ones, and found that regulatory
function was compromised. The myofibrils relaxed more
slowly and incompletely, indicating an increased contribu-
tion of the open state in the absence of Ca2þ (M). These
studies emphasize that the amino acid sequence of Tm didBiophysical Journal 112, 376–387, January 24, 2017 385
Scellini et al.not evolve for maximum stability, but rather reflects the
properties that Tm needs to function within the finely
coupled equilibria of muscle regulation involving interac-
tions with actin, Tn, and myosin. Its sequence reflects the
need for Tm to 1) be water soluble and properly folded un-
der physiological conditions; 2) interact sufficiently weakly
with actin to allow Tm movement upon Ca2þ binding to Tn;
3) interact with Tn and actin strongly enough to block initial
weak myosin binding, yet allow force-generating, strong
myosin binding; 4) interact end-to-end with itself to provide
continuity; and 5) have the right flexibility to facilitate
conformational changes during changing protein interac-
tions and to be able to transmit perturbing signals produced
by Tn and myosin. This study also provides a basis for un-
derstanding how single Tm mutations involved in cardiomy-
opathies can compromise function.AUTHOR CONTRIBUTIONS
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